In a nutshell Drugs commonly used to treat HIV and hepatitis B (called NRTIs) were found to reduce the risk of developing ...

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the ...

In the face of a fear of loss of funds for ending the HIV/AIDS epidemic, activists in New Jersey walked to raise money.

Exclusive: World Health Organisation says shortage of most commonly used Aids drug caused by withdrawal of US foreign aid ...

On April 22, the CDC allegedly informed Emory University in Atlanta that its large HIV self-testing program was being ...

NEW YORK (Reuters) -Gilead Sciences has reached a $202 million settlement to resolve a civil fraud lawsuit accusing the ...

Long-acting injectable antiretroviral therapy (ART) can be administered at home to persons living with HIV as safely and ...